CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update


You May Also Like

Rheumatology Community Urges CMS to Proceed with Caution When Considering IPI Drug Pricing Model

ACR Recommends CMS Make Drug Pricing Demonstration Voluntary; Better Address Financial and Administrative Challenges ...

Positive Afrezza® Clinical Data from STAT Study Published in Diabetes Technology & Therapeutics

Study data show Afrezza provides greater improvement in postprandial glucose control than insulin aspartWESTLAKE ...